Icu Medical INC/DE SEC filings ICUI

Icu Medical INC/DE has 1,000 filings in SEC EDGAR's recent list, going back to Jul 25, 2013. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Icu Medical INC/DE SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Sep 3, 2026 Sep 3, 2026
144 Notice of proposed sale Sep 3, 2026 —
4 Insider transaction Sep 1, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 1, 2026 —
4 Insider transaction Aug 31, 2026 Aug 31, 2026
144 Notice of proposed sale Aug 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 13, 2026 Aug 13, 2026
144 Notice of proposed sale Aug 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
4 Insider transaction Aug 12, 2026 Aug 12, 2026
144 Notice of proposed sale Aug 12, 2026 —
4 Insider transaction Aug 11, 2026 Aug 11, 2026
4 Insider transaction Aug 11, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 11, 2026 —
144 Notice of proposed sale Aug 11, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SD Specialized disclosure (conflict minerals) Jun 1, 2026 —
144 Notice of proposed sale May 22, 2026 —
4 Insider transaction May 22, 2026 May 22, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 18, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 14, 2026
144 Notice of proposed sale May 14, 2026 —
4 Insider transaction May 13, 2026 May 13, 2026
4 Insider transaction May 13, 2026 May 13, 2026
4 Insider transaction May 13, 2026 May 13, 2026
4 Insider transaction May 13, 2026 May 13, 2026
4 Insider transaction May 13, 2026 May 13, 2026
4 Insider transaction May 13, 2026 May 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2026 —
144 Notice of proposed sale May 12, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
ARS Annual report to shareholders Apr 2, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 2, 2026 —
DEF 14A Proxy statement Apr 2, 2026 May 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 26, 2026 Mar 25, 2026
PRE 14A Preliminary proxy statement Mar 23, 2026 Dec 31, 2025
4 Insider transaction Mar 16, 2026 Mar 15, 2026
4 Insider transaction Mar 16, 2026 Mar 15, 2026
4 Insider transaction Mar 16, 2026 Mar 15, 2026
4 Insider transaction Mar 16, 2026 Mar 15, 2026
4 Insider transaction Mar 16, 2026 Mar 15, 2026
4 Insider transaction Mar 16, 2026 Mar 15, 2026
4 Insider transaction Mar 9, 2026 Mar 7, 2026
4 Insider transaction Mar 9, 2026 Mar 7, 2026
4 Insider transaction Mar 9, 2026 Mar 7, 2026
4 Insider transaction Mar 9, 2026 Mar 7, 2026
4 Insider transaction Mar 9, 2026 Mar 7, 2026
4 Insider transaction Mar 9, 2026 Mar 7, 2026
8-K Current report
Officer or director change
Feb 20, 2026 Feb 20, 2026
10-K Annual report Feb 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 25, 2025 Nov 25, 2025
4 Insider transaction Nov 12, 2025 Nov 11, 2025
4 Insider transaction Nov 12, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 12, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Sep 15, 2025 Sep 12, 2025
4 Insider transaction Aug 27, 2025 Aug 27, 2025
4 Insider transaction Aug 14, 2025 Aug 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
S-8 Employee stock plan registration Aug 8, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SD Specialized disclosure (conflict minerals) May 30, 2025 —
144 Notice of proposed sale May 30, 2025 —
4 Insider transaction May 30, 2025 May 30, 2025
4 Insider transaction May 28, 2025 May 27, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 21, 2025 May 20, 2025
4 Insider transaction May 20, 2025 May 19, 2025
4 Insider transaction May 19, 2025 May 16, 2025
144 Notice of proposed sale May 19, 2025 —
4 Insider transaction May 15, 2025 May 14, 2025
4 Insider transaction May 15, 2025 May 15, 2025
144 Notice of proposed sale May 15, 2025 —
144 Notice of proposed sale May 14, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
May 14, 2025 May 13, 2025
4 Insider transaction May 14, 2025 May 13, 2025
4 Insider transaction May 13, 2025 May 13, 2025
4 Insider transaction May 13, 2025 May 13, 2025
4 Insider transaction May 13, 2025 May 13, 2025
4 Insider transaction May 13, 2025 May 13, 2025
4 Insider transaction May 13, 2025 May 13, 2025
144 Notice of proposed sale May 13, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
ARS Annual report to shareholders Apr 3, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 3, 2025 —
DEF 14A Proxy statement Apr 3, 2025 Apr 3, 2025
4 Insider transaction Mar 17, 2025 Mar 15, 2025
4 Insider transaction Mar 17, 2025 Mar 15, 2025
4 Insider transaction Mar 17, 2025 Mar 15, 2025
4 Insider transaction Mar 17, 2025 Mar 15, 2025
4 Insider transaction Mar 17, 2025 Mar 15, 2025
4 Insider transaction Mar 17, 2025 Mar 15, 2025
4 Insider transaction Mar 14, 2025 Mar 7, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Jan 2, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Dec 6, 2024 —
4 Insider transaction Dec 6, 2024 Dec 6, 2024
4 Insider transaction Dec 2, 2024 Dec 2, 2024
144 Notice of proposed sale Dec 2, 2024 —
4 Insider transaction Nov 27, 2024 Nov 27, 2024
4 Insider transaction Nov 27, 2024 Nov 27, 2024
144 Notice of proposed sale Nov 27, 2024 —
4 Insider transaction Nov 26, 2024 Nov 25, 2024
144 Notice of proposed sale Nov 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
4 Insider transaction Nov 4, 2024 Nov 1, 2024
144 Notice of proposed sale Nov 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
8-K Current report
Officer or director change
Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 1, 2024 Oct 1, 2024
144 Notice of proposed sale Oct 1, 2024 —
4 Insider transaction Sep 3, 2024 Sep 3, 2024
144 Notice of proposed sale Sep 3, 2024 —
4 Insider transaction Aug 30, 2024 Aug 30, 2024
144 Notice of proposed sale Aug 30, 2024 —
4 Insider transaction Aug 16, 2024 Aug 16, 2024
144 Notice of proposed sale Aug 16, 2024 —
144 Notice of proposed sale Aug 13, 2024 —
4 Insider transaction Aug 8, 2024 Aug 8, 2024
144 Notice of proposed sale Aug 8, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
SC 13D/A Amended ownership over 5% (active) Jul 18, 2024 —
144 Notice of proposed sale Jul 16, 2024 —
SD Specialized disclosure (conflict minerals) May 31, 2024 —
4 Insider transaction May 30, 2024 May 30, 2024
144 Notice of proposed sale May 30, 2024 —
4 Insider transaction May 16, 2024 May 16, 2024
8-K Current report
Shareholder vote results
May 16, 2024 May 15, 2024
4 Insider transaction May 15, 2024 May 15, 2024
4 Insider transaction May 15, 2024 May 15, 2024
4 Insider transaction May 15, 2024 May 15, 2024
4 Insider transaction May 15, 2024 May 15, 2024
4 Insider transaction May 15, 2024 May 15, 2024
4 Insider transaction May 15, 2024 May 15, 2024
144 Notice of proposed sale May 10, 2024 —
4 Insider transaction May 10, 2024 May 10, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 2, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 2, 2024 —
DEF 14A Proxy statement Apr 2, 2024 May 15, 2024
4 Insider transaction Mar 18, 2024 Mar 15, 2024
4 Insider transaction Mar 18, 2024 Mar 15, 2024
4 Insider transaction Mar 18, 2024 Mar 15, 2024
4 Insider transaction Mar 18, 2024 Mar 15, 2024
4 Insider transaction Mar 18, 2024 Mar 15, 2024
4 Insider transaction Mar 18, 2024 Mar 15, 2024
4 Insider transaction Mar 15, 2024 Mar 15, 2024
144 Notice of proposed sale Mar 15, 2024 —
4 Insider transaction Mar 14, 2024 Mar 14, 2024
4/A Primary document Mar 14, 2024 Mar 12, 2024
4 Insider transaction Mar 13, 2024 Mar 11, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 11, 2024 Mar 4, 2024
144 Notice of proposed sale Mar 8, 2024 —
144 Notice of proposed sale Mar 8, 2024 —
144 Notice of proposed sale Mar 5, 2024 —
4 Insider transaction Mar 5, 2024 Mar 4, 2024
144 Notice of proposed sale Mar 4, 2024 —
4 Insider transaction Mar 1, 2024 Feb 29, 2024
4 Insider transaction Mar 1, 2024 Feb 29, 2024
SC 13D/A Amended ownership over 5% (active) Mar 1, 2024 —
144 Notice of proposed sale Feb 29, 2024 —
8-K Current report
Officer or director change
Feb 29, 2024 Feb 28, 2024
10-K Annual report Feb 27, 2024 Dec 31, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ICUI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Clemente, CA
SEC filer status
Large accelerated filer
SEC CIK
883984

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.